KELLI FARM: Open Payments
NPI 1639568496 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,675 in 169 payments from 16 companies in 2025. Trend: 2023 $3,607 · 2024 $3,134 · 2025 $3,675
Food & beverage: $3,462Education: $213
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $789 |
| Janssen Biotech, Inc. | 31 | $687 |
| UCB, Inc. | 21 | $573 |
| Regeneron Healthcare Solutions, Inc. | 15 | $368 |
| Novartis Pharmaceuticals Corporation | 24 | $357 |
| Organon LLC | 5 | $191 |
| PFIZER INC. | 7 | $158 |
| GENZYME CORPORATION | 5 | $135 |
| Amgen Inc. | 4 | $92 |
| Lilly USA, LLC | 4 | $80 |
Products named: TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, COSENTYX, RINVOQ, VTAMA, CIBINQO.
Industry payments across OR — which companies pay providers there.
